<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-07-25" modified="2017-11-22" version="126">
<accession>Q9NR71</accession>
<accession>Q3KNU1</accession>
<accession>Q5SNT7</accession>
<accession>Q5SZP6</accession>
<accession>Q5SZP7</accession>
<accession>Q5T1D5</accession>
<accession>Q71ME6</accession>
<name>ASAH2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Neutral ceramidase</fullName>
<shortName>N-CDase</shortName>
<shortName>NCDase</shortName>
<ecNumber>3.5.1.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Acylsphingosine deacylase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>BCDase</fullName>
</alternativeName>
<alternativeName>
<fullName>LCDase</fullName>
<shortName>hCD</shortName>
</alternativeName>
<alternativeName>
<fullName>N-acylsphingosine amidohydrolase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Non-lysosomal ceramidase</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Neutral ceramidase soluble form</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">ASAH2</name>
<name type="synonym">HNAC1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Gene" volume="315" first="113" last="122">
<title>Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.</title>
<authorList>
<person name="Choi M.S."/>
<person name="Anderson M.A."/>
<person name="Zhang Z."/>
<person name="Zimonjic D.B."/>
<person name="Popescu N."/>
<person name="Mukherjee A.B."/>
</authorList>
<dbReference type="PubMed" id="14557071"/>
<dbReference type="DOI" id="10.1016/S0378-1119(03)00721-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="27879" last="27887">
<title>Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.</title>
<authorList>
<person name="Osawa Y."/>
<person name="Uchinami H."/>
<person name="Bielawski J."/>
<person name="Schwabe R.F."/>
<person name="Hannun Y.A."/>
<person name="Brenner D.A."/>
</authorList>
<dbReference type="PubMed" id="15946935"/>
<dbReference type="DOI" id="10.1074/jbc.M503002200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="21508" last="21513">
<title>Molecular cloning and characterization of a human mitochondrial ceramidase.</title>
<authorList>
<person name="El Bawab S."/>
<person name="Roddy P."/>
<person name="Qian T."/>
<person name="Bielawska A."/>
<person name="Lemasters J.J."/>
<person name="Hannun Y.A."/>
</authorList>
<dbReference type="PubMed" id="10781606"/>
<dbReference type="DOI" id="10.1074/jbc.M002522200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 20-780 (ISOFORM 1)</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>POSSIBLE SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-780 (ISOFORM 2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="331" first="37" last="42">
<title>Subcellular localization of human neutral ceramidase expressed in HEK293 cells.</title>
<authorList>
<person name="Hwang Y.H."/>
<person name="Tani M."/>
<person name="Nakagawa T."/>
<person name="Okino N."/>
<person name="Ito M."/>
</authorList>
<dbReference type="PubMed" id="15845354"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.03.134"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="J. Lipid Res." volume="46" first="2458" last="2467">
<title>Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.</title>
<authorList>
<person name="Tani M."/>
<person name="Sano T."/>
<person name="Ito M."/>
<person name="Igarashi Y."/>
</authorList>
<dbReference type="PubMed" id="16061940"/>
<dbReference type="DOI" id="10.1194/jlr.M500268-JLR200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Biochem. J." volume="393" first="687" last="695">
<title>Identification of a novel amidase motif in neutral ceramidase.</title>
<authorList>
<person name="Galadari S."/>
<person name="Wu B.X."/>
<person name="Mao C."/>
<person name="Roddy P."/>
<person name="El Bawab S."/>
<person name="Hannun Y.A."/>
</authorList>
<dbReference type="PubMed" id="16229686"/>
<dbReference type="DOI" id="10.1042/BJ20050682"/>
</citation>
<scope>ENZYME ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF SER-258; ASP-352; SER-354; CYS-362; SER-374; SER-396; SER-595 AND SER-729</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Neurogenetics" volume="8" first="111" last="120">
<title>A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.</title>
<authorList>
<person name="Avramopoulos D."/>
<person name="Wang R."/>
<person name="Valle D."/>
<person name="Fallin M.D."/>
<person name="Bassett S.S."/>
</authorList>
<dbReference type="PubMed" id="17334805"/>
<dbReference type="DOI" id="10.1007/s10048-007-0081-5"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<comment type="function">
<text evidence="6 7">Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5. Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16-ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract.</text>
</comment>
<comment type="catalytic activity">
<text evidence="4 8">N-acylsphingosine + H(2)O = a carboxylate + sphingosine.</text>
</comment>
<comment type="enzyme regulation">
<text>Inhibited by dithiothreitol (DTT), 2-mercaptoethanol, Zn(2+), Cu(2+) and Fe(2+). Enhanced by Na(+) and Ca(2+), and at lower level Mg(2+) and Mn(2+).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="4 8">71.4 uM for octanoyl-sphingosine</KM>
<KM evidence="4 8">66 uM for palmitoyl-sphingosine</KM>
<KM evidence="4 8">60.1 uM for D-erythro-C12-NBD-ceramide</KM>
<Vmax evidence="4 8">160 umol/min/mg enzyme with octanoyl-sphingosine as substrate</Vmax>
<Vmax evidence="4 8">16 umol/min/mg enzyme with palmitoyl-sphingosine as substrate</Vmax>
<Vmax evidence="4 8">0.68 nmol/min/mg enzyme with D-erythro-C12-NBD-ceramide as substrate</Vmax>
</kinetics>
<phDependence>
<text evidence="4 8">Optimum pH is 7.5-9.5.</text>
</phDependence>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cell membrane</location>
<topology evidence="5">Single-pass type II membrane protein</topology>
</subcellularLocation>
<text>The neutral ceramidase soluble form is a secreted protein. According to PubMed:10781606, it is mitochondrial. However, they used a shorter form in its N-terminus, which may explain this localization which probably does not exist in vivo.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NR71-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NR71-2</id>
<name>2</name>
<sequence type="described" ref="VSP_019928"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="4 9">Primarily expressed in the intestine (PubMed:17334805). Ubiquitously expressed with higher levels in kidney, skeletal muscle and heart (PubMed:10781606). According to PubMed:17334805, ubiquitous expression attributed to ASAH2 may be actually that of the paralog ASAH2B.</text>
</comment>
<comment type="PTM">
<text evidence="2">N-glycosylated. Required for enzyme activity (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="5">O-glycosylated. Required to retain it as a type II membrane protein at the cell surface.</text>
</comment>
<comment type="PTM">
<text evidence="2">Phosphorylated. May prevent ubiquitination and subsequent degradation (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="2">Ubiquitinated, leading to its degradation by the proteasome. Ubiquitination is triggered by nitric oxid (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the neutral ceramidase family.</text>
</comment>
<comment type="sequence caution" evidence="11">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAL06061" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="11">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAI15870" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="3.5.1.23"/>
<dbReference type="EMBL" id="AY049008">
<property type="protein sequence ID" value="AAL06061.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF449759">
<property type="protein sequence ID" value="AAQ04667.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL450382">
<property type="protein sequence ID" value="CAI15870.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL589794">
<property type="protein sequence ID" value="CAI15766.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL589794">
<property type="protein sequence ID" value="CAI15767.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL954360">
<property type="protein sequence ID" value="CAI17190.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF250847">
<property type="protein sequence ID" value="AAF86240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC107105">
<property type="protein sequence ID" value="AAI07106.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44398.1">
<molecule id="Q9NR71-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7239.2">
<molecule id="Q9NR71-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001137446.1">
<molecule id="Q9NR71-2"/>
<property type="nucleotide sequence ID" value="NM_001143974.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_063946.2">
<molecule id="Q9NR71-1"/>
<property type="nucleotide sequence ID" value="NM_019893.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011538272.1">
<molecule id="Q9NR71-1"/>
<property type="nucleotide sequence ID" value="XM_011539970.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.512645"/>
<dbReference type="UniGene" id="Hs.659820"/>
<dbReference type="PDB" id="4WGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B=99-780"/>
</dbReference>
<dbReference type="PDBsum" id="4WGK"/>
<dbReference type="ProteinModelPortal" id="Q9NR71"/>
<dbReference type="SMR" id="Q9NR71"/>
<dbReference type="STRING" id="9606.ENSP00000378897"/>
<dbReference type="BindingDB" id="Q9NR71"/>
<dbReference type="ChEMBL" id="CHEMBL2021754"/>
<dbReference type="SwissLipids" id="SLP:000000163"/>
<dbReference type="iPTMnet" id="Q9NR71"/>
<dbReference type="PhosphoSitePlus" id="Q9NR71"/>
<dbReference type="BioMuta" id="ASAH2"/>
<dbReference type="DMDM" id="110832757"/>
<dbReference type="MaxQB" id="Q9NR71"/>
<dbReference type="PaxDb" id="Q9NR71"/>
<dbReference type="PeptideAtlas" id="Q9NR71"/>
<dbReference type="PRIDE" id="Q9NR71"/>
<dbReference type="Ensembl" id="ENST00000395526">
<molecule id="Q9NR71-1"/>
<property type="protein sequence ID" value="ENSP00000378897"/>
<property type="gene ID" value="ENSG00000188611"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000447815">
<molecule id="Q9NR71-2"/>
<property type="protein sequence ID" value="ENSP00000388206"/>
<property type="gene ID" value="ENSG00000188611"/>
</dbReference>
<dbReference type="GeneID" id="56624"/>
<dbReference type="KEGG" id="hsa:56624"/>
<dbReference type="UCSC" id="uc001jjd.4">
<molecule id="Q9NR71-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="56624"/>
<dbReference type="DisGeNET" id="56624"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000188611.14"/>
<dbReference type="GeneCards" id="ASAH2"/>
<dbReference type="H-InvDB" id="HIX0058802"/>
<dbReference type="HGNC" id="HGNC:18860">
<property type="gene designation" value="ASAH2"/>
</dbReference>
<dbReference type="HPA" id="HPA061171"/>
<dbReference type="MIM" id="611202">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NR71"/>
<dbReference type="OpenTargets" id="ENSG00000188611"/>
<dbReference type="PharmGKB" id="PA134977109"/>
<dbReference type="eggNOG" id="KOG2232">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQWE">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000015792"/>
<dbReference type="HOVERGEN" id="HBG080870"/>
<dbReference type="InParanoid" id="Q9NR71"/>
<dbReference type="KO" id="K12349"/>
<dbReference type="OMA" id="GAWCDDG"/>
<dbReference type="OrthoDB" id="EOG091G06OC"/>
<dbReference type="PhylomeDB" id="Q9NR71"/>
<dbReference type="TreeFam" id="TF300786"/>
<dbReference type="BRENDA" id="3.5.1.23">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660662">
<property type="pathway name" value="Glycosphingolipid metabolism"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9NR71"/>
<dbReference type="GeneWiki" id="ASAH2"/>
<dbReference type="GenomeRNAi" id="56624"/>
<dbReference type="PRO" id="PR:Q9NR71"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000188611"/>
<dbReference type="CleanEx" id="HS_ASAH2"/>
<dbReference type="ExpressionAtlas" id="Q9NR71">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NR71">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0017040">
<property type="term" value="F:ceramidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006672">
<property type="term" value="P:ceramide metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR006823">
<property type="entry name" value="Ceramidase_alk"/>
</dbReference>
<dbReference type="InterPro" id="IPR031331">
<property type="entry name" value="NEUT/ALK_ceramidase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR031329">
<property type="entry name" value="NEUT/ALK_ceramidase_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12670">
<property type="entry name" value="PTHR12670"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04734">
<property type="entry name" value="Ceramidase_alk"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17048">
<property type="entry name" value="Ceramidse_alk_C"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0746">Sphingolipid metabolism</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Neutral ceramidase" id="PRO_0000247099">
<location>
<begin position="1"/>
<end position="780"/>
</location>
</feature>
<feature type="chain" description="Neutral ceramidase soluble form" id="PRO_0000247100" evidence="2">
<location>
<begin position="99"/>
<end position="780"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="1"/>
<end position="12"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="3">
<location>
<begin position="13"/>
<end position="33"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="3">
<location>
<begin position="34"/>
<end position="780"/>
</location>
</feature>
<feature type="region of interest" description="Required for correct folding and localization" evidence="2">
<location>
<begin position="770"/>
<end position="780"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="8">
<location>
<position position="354"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="62"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="67"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="68"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="70"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="73"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="74"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="76"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="78"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="3">
<location>
<position position="79"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="80"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="82"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="84"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="98"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="151"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="217"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="468"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="564"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="730"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="3">
<location>
<position position="779"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_019928" evidence="10">
<location>
<begin position="410"/>
<end position="444"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7067625." id="VAR_027064">
<original>T</original>
<variation>A</variation>
<location>
<position position="51"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs993869." id="VAR_027065">
<original>A</original>
<variation>S</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs enzyme activity." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="8">
<original>D</original>
<variation>A</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs enzyme activity." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs enzyme activity." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs enzyme activity." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAL06061 and 4; AAF86240." ref="1 4" evidence="11">
<original>S</original>
<variation>P</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAL06061 and 4; AAF86240." ref="1 4" evidence="11">
<original>T</original>
<variation>A</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAI17190." ref="3" evidence="11">
<original>T</original>
<variation>N</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="129"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="138"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="153"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="165"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="185"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="206"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="217"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="239"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="255"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="259"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="280"/>
<end position="288"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="293"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="317"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="342"/>
<end position="346"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="360"/>
<end position="362"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="380"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="389"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="393"/>
<end position="413"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="423"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="444"/>
<end position="446"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="454"/>
<end position="458"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="478"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="493"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="513"/>
<end position="515"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="520"/>
<end position="529"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="532"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="538"/>
<end position="541"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="543"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="566"/>
<end position="570"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="572"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="578"/>
<end position="580"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="583"/>
<end position="588"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="591"/>
<end position="594"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="602"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="622"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="658"/>
<end position="660"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="664"/>
<end position="667"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="670"/>
<end position="677"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="681"/>
<end position="684"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="693"/>
<end position="700"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="701"/>
<end position="704"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="705"/>
<end position="711"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="717"/>
<end position="723"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="729"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="744"/>
<end position="756"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="764"/>
<end position="771"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="775"/>
<end position="779"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WGK"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10781606"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15845354"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15946935"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16061940"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16229686"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17334805"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<sequence length="780" mass="85516" checksum="D2BD7947B022A619" modified="2006-07-25" version="2">
MAKRTFSNLETFLIFLLVMMSAITVALLSLLFITSGTIENHKDLGGHFFSTTQSPPATQG
STAAQRSTATQHSTATQSSTATQTSPVPLTPESPLFQNFSGYHIGVGRADCTGQVADINL
MGYGKSGQNAQGILTRLYSRAFIMAEPDGSNRTVFVSIDIGMVSQRLRLEVLNRLQSKYG
SLYRRDNVILSGTHTHSGPAGYFQYTVFVIASEGFSNQTFQHMVTGILKSIDIAHTNMKP
GKIFINKGNVDGVQINRSPYSYLQNPQSERARYSSNTDKEMIVLKMVDLNGDDLGLISWF
AIHPVSMNNSNHLVNSDNVGYASYLLEQEKNKGYLPGQGPFVAAFASSNLGDVSPNILGP
RCINTGESCDNANSTCPIGGPSMCIAKGPGQDMFDSTQIIGRAMYQRAKELYASASQEVT
GPLASAHQWVDMTDVTVWLNSTHASKTCKPALGYSFAAGTIDGVGGLNFTQGKTEGDPFW
DTIRDQILGKPSEEIKECHKPKPILLHTGELSKPHPWHPDIVDVQIITLGSLAITAIPGE
FTTMSGRRLREAVQAEFASHGMQNMTVVISGLCNVYTHYITTYEEYQAQRYEAASTIYGP
HTLSAYIQLFRNLAKAIATDTVANLSRGPEPPFFKQLIVPLIPSIVDRAPKGRTFGDVLQ
PAKPEYRVGEVAEVIFVGANPKNSVQNQTHQTFLTVEKYEATSTSWQIVCNDASWETRFY
WHKGLLGLSNATVEWHIPDTAQPGIYRIRYFGHNRKQDILKPAVILSFEGTSPAFEVVTI
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>